Aurobindo’s lipid-lowering drug recalled

Our Bureau Hyderabad | Updated on September 08, 2019 Published on September 08, 2019

Aurobindo Pharma Ltd has recalled 2,352 bottles of lipid-lowering Simvastatin tablets from the US market, according information available with the US Food and Drug Administration. According to the US Regulator, this was a ‘voluntary recall’. The drug was manufactured by the US arm of Hyderabad-based Aurobindo, Aurolife Pharma LLC, the USFDA said. The reason for has been mentioned as “labelling; incorrect or missing lot and/or exp date,” the US regulator said. The product was distributed nationwide by three major distributors who may have further distributed the product, the report said.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on September 08, 2019
This article is closed for comments.
Please Email the Editor